The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung

Yuben P. Moodley, Jesse D. Armitage, Dino B.A. Tan

Research output: Chapter in Book/Conference paperChapter

Abstract

Chronic lung disease is responsible for approximately 7% of all deaths worldwide and represents 4% of the global burden of disease. Mesenchymal stromal cells (MSCs) have anti‐inflammatory properties that can reduce inflammatory pathways as well as possibly replacing damaged lung tissue. MSCs derived from different sources, including the placenta, umbilical cord, and adipose tissue have these anti‐inflammatory actions. MSCs are part of the connective tissue framework that provides both structural and physiological support to parenchymal cells in multiple organs. MSCs not only are used as direct therapy for lung disorders but may also be used as engineered vectors for drug delivery to specific sites. Chronic obstructive pulmonary disease (COPD) is the commonest respiratory condition in the world. The optimal dose and route of delivery of MSCs remain to be determined and may be dependent on the lung disease itself.
Original languageEnglish
Title of host publicationThe Biology and Therapeutic Application of Mesenchymal Cells
EditorsKerry Atkinson
Place of PublicationUnited States
PublisherJohn Wiley & Sons
Chapter52
Pages770-786
ISBN (Electronic)9781118907474
ISBN (Print)9781118907511
DOIs
Publication statusPublished - 2016

Fingerprint

Mesenchymal Stromal Cells
Lung Diseases
Anti-Inflammatory Agents
Lung
Umbilical Cord
Connective Tissue
Chronic Obstructive Pulmonary Disease
Placenta
Adipose Tissue
Chronic Disease
Pharmaceutical Preparations
Therapeutics

Cite this

Moodley, Y. P., Armitage, J. D., & Tan, D. B. A. (2016). The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung. In K. Atkinson (Ed.), The Biology and Therapeutic Application of Mesenchymal Cells (pp. 770-786). United States: John Wiley & Sons. https://doi.org/10.1002/9781118907474.ch52
Moodley, Yuben P. ; Armitage, Jesse D. ; Tan, Dino B.A. / The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung. The Biology and Therapeutic Application of Mesenchymal Cells. editor / Kerry Atkinson. United States : John Wiley & Sons, 2016. pp. 770-786
@inbook{6842ac0eee9f49f78b8b7d502d3a06d4,
title = "The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung",
abstract = "Chronic lung disease is responsible for approximately 7{\%} of all deaths worldwide and represents 4{\%} of the global burden of disease. Mesenchymal stromal cells (MSCs) have anti‐inflammatory properties that can reduce inflammatory pathways as well as possibly replacing damaged lung tissue. MSCs derived from different sources, including the placenta, umbilical cord, and adipose tissue have these anti‐inflammatory actions. MSCs are part of the connective tissue framework that provides both structural and physiological support to parenchymal cells in multiple organs. MSCs not only are used as direct therapy for lung disorders but may also be used as engineered vectors for drug delivery to specific sites. Chronic obstructive pulmonary disease (COPD) is the commonest respiratory condition in the world. The optimal dose and route of delivery of MSCs remain to be determined and may be dependent on the lung disease itself.",
author = "Moodley, {Yuben P.} and Armitage, {Jesse D.} and Tan, {Dino B.A.}",
year = "2016",
doi = "10.1002/9781118907474.ch52",
language = "English",
isbn = "9781118907511",
pages = "770--786",
editor = "Atkinson, {Kerry }",
booktitle = "The Biology and Therapeutic Application of Mesenchymal Cells",
publisher = "John Wiley & Sons",
address = "United States",

}

Moodley, YP, Armitage, JD & Tan, DBA 2016, The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung. in K Atkinson (ed.), The Biology and Therapeutic Application of Mesenchymal Cells. John Wiley & Sons, United States, pp. 770-786. https://doi.org/10.1002/9781118907474.ch52

The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung. / Moodley, Yuben P.; Armitage, Jesse D.; Tan, Dino B.A.

The Biology and Therapeutic Application of Mesenchymal Cells. ed. / Kerry Atkinson. United States : John Wiley & Sons, 2016. p. 770-786.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung

AU - Moodley, Yuben P.

AU - Armitage, Jesse D.

AU - Tan, Dino B.A.

PY - 2016

Y1 - 2016

N2 - Chronic lung disease is responsible for approximately 7% of all deaths worldwide and represents 4% of the global burden of disease. Mesenchymal stromal cells (MSCs) have anti‐inflammatory properties that can reduce inflammatory pathways as well as possibly replacing damaged lung tissue. MSCs derived from different sources, including the placenta, umbilical cord, and adipose tissue have these anti‐inflammatory actions. MSCs are part of the connective tissue framework that provides both structural and physiological support to parenchymal cells in multiple organs. MSCs not only are used as direct therapy for lung disorders but may also be used as engineered vectors for drug delivery to specific sites. Chronic obstructive pulmonary disease (COPD) is the commonest respiratory condition in the world. The optimal dose and route of delivery of MSCs remain to be determined and may be dependent on the lung disease itself.

AB - Chronic lung disease is responsible for approximately 7% of all deaths worldwide and represents 4% of the global burden of disease. Mesenchymal stromal cells (MSCs) have anti‐inflammatory properties that can reduce inflammatory pathways as well as possibly replacing damaged lung tissue. MSCs derived from different sources, including the placenta, umbilical cord, and adipose tissue have these anti‐inflammatory actions. MSCs are part of the connective tissue framework that provides both structural and physiological support to parenchymal cells in multiple organs. MSCs not only are used as direct therapy for lung disorders but may also be used as engineered vectors for drug delivery to specific sites. Chronic obstructive pulmonary disease (COPD) is the commonest respiratory condition in the world. The optimal dose and route of delivery of MSCs remain to be determined and may be dependent on the lung disease itself.

U2 - 10.1002/9781118907474.ch52

DO - 10.1002/9781118907474.ch52

M3 - Chapter

SN - 9781118907511

SP - 770

EP - 786

BT - The Biology and Therapeutic Application of Mesenchymal Cells

A2 - Atkinson, Kerry

PB - John Wiley & Sons

CY - United States

ER -

Moodley YP, Armitage JD, Tan DBA. The biology and potential clinical applications of mesenchymal stromal cells in diseases of the lung. In Atkinson K, editor, The Biology and Therapeutic Application of Mesenchymal Cells. United States: John Wiley & Sons. 2016. p. 770-786 https://doi.org/10.1002/9781118907474.ch52